These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26812788)

  • 1. Highlight: Perspectives of molecular neuroscience in health and disease.
    Heumann R
    Biol Chem; 2016 Mar; 397(3):175. PubMed ID: 26812788
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.
    Sureda FX; Junyent F; Verdaguer E; Auladell C; Pelegri C; Vilaplana J; Folch J; Canudas AM; Zarate CB; Pallès M; Camins A
    Curr Pharm Des; 2011; 17(3):230-45. PubMed ID: 21348832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen as a neuroprotective hormone.
    Behl C
    Nat Rev Neurosci; 2002 Jun; 3(6):433-42. PubMed ID: 12042878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human embryonic stem cells: a resource for in vitro neuroscience research?
    Norman TR
    Neuropsychopharmacology; 2006 Dec; 31(12):2571-2. PubMed ID: 17109013
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic antioxidants for neurodegenerative disease.
    Linseman DA
    Recent Pat CNS Drug Discov; 2012 Dec; 7(3):183. PubMed ID: 22857712
    [No Abstract]   [Full Text] [Related]  

  • 6. Modeling neurodegenerative diseases using stem cells: is it accelerating drug discovery?
    Ebert AD
    Future Med Chem; 2012 Sep; 4(13):1651-3. PubMed ID: 22924501
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenamates as Potential Therapeutics for Neurodegenerative Disorders.
    Hill J; Zawia NH
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
    Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
    Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of neurodegeneration and neuroprotection--experimental approaches and the diseased brain.
    Schliebs R
    Int J Dev Neurosci; 2004 Nov; 22(7):441-2. PubMed ID: 15465273
    [No Abstract]   [Full Text] [Related]  

  • 10. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
    Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron damage and protection. Introduction.
    Hu G
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):564-5. PubMed ID: 22490086
    [No Abstract]   [Full Text] [Related]  

  • 12. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
    Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of resveratrol against glutamate-induced excitotoxicity.
    Zhang LN; Hao L; Wang HY; Su HN; Sun YJ; Yang XY; Che B; Xue J; Gao ZB
    Adv Clin Exp Med; 2015; 24(1):161-5. PubMed ID: 25923101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward neurotrophin-based therapeutics.
    Monteggia LM
    Am J Psychiatry; 2011 Feb; 168(2):114-6. PubMed ID: 21297044
    [No Abstract]   [Full Text] [Related]  

  • 15. Interfering with programmed cell death in neurodegenerative diseases: insights from experimental animal models.
    Vila M
    Drug Discov Today; 2004 Jun; 9(12):513-4. PubMed ID: 15183156
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurogenesis as a potential therapeutic strategy for neurodegenerative disorders.
    Kelleher-Andersson J
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S19-25. PubMed ID: 15665409
    [No Abstract]   [Full Text] [Related]  

  • 17. Metal attenuating therapies in neurodegenerative disease.
    Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
    Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery.
    Shi Y; Mader M
    Bioorg Med Chem Lett; 2018 Jun; 28(11):1981-1991. PubMed ID: 29752185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Caenorhabditis elegans models of neurodegenerative disease to identify neuroprotective strategies.
    Kraemer B; Schellenberg GD
    Int Rev Neurobiol; 2007; 77():219-46. PubMed ID: 17178476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leptin as a neuroprotector and functional stability factor in the central neural system].
    Teryaeva NB
    Ross Fiziol Zh Im I M Sechenova; 2013 Oct; 99(10):1138-48. PubMed ID: 25434226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.